SG11202011004RA - Hepatitis b vaccine transnasal administration system - Google Patents
Hepatitis b vaccine transnasal administration systemInfo
- Publication number
- SG11202011004RA SG11202011004RA SG11202011004RA SG11202011004RA SG11202011004RA SG 11202011004R A SG11202011004R A SG 11202011004RA SG 11202011004R A SG11202011004R A SG 11202011004RA SG 11202011004R A SG11202011004R A SG 11202011004RA SG 11202011004R A SG11202011004R A SG 11202011004RA
- Authority
- SG
- Singapore
- Prior art keywords
- vaccine
- hepatitis
- administration system
- transnasal administration
- transnasal
- Prior art date
Links
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/34—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl
- B05B1/3405—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018107797 | 2018-06-05 | ||
PCT/JP2019/022136 WO2019235466A1 (ja) | 2018-06-05 | 2019-06-04 | B型肝炎ワクチン経鼻投与システム |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202011004RA true SG11202011004RA (en) | 2020-12-30 |
Family
ID=68769323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202011004RA SG11202011004RA (en) | 2018-06-05 | 2019-06-04 | Hepatitis b vaccine transnasal administration system |
Country Status (15)
Country | Link |
---|---|
US (1) | US20210187101A1 (ko) |
EP (1) | EP3804752A4 (ko) |
JP (1) | JPWO2019235466A1 (ko) |
KR (1) | KR20210022009A (ko) |
CN (1) | CN112368018A (ko) |
AU (1) | AU2019283122A1 (ko) |
BR (1) | BR112020022784A2 (ko) |
CA (1) | CA3099430A1 (ko) |
CU (1) | CU24686B1 (ko) |
IL (1) | IL278415B2 (ko) |
MX (1) | MX2020013240A (ko) |
PH (1) | PH12020552075A1 (ko) |
SG (1) | SG11202011004RA (ko) |
TW (1) | TW202002950A (ko) |
WO (1) | WO2019235466A1 (ko) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19851282A1 (de) * | 1998-11-06 | 2000-05-11 | Schweiz Serum & Impfinst | Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten |
CU22871A1 (es) * | 1998-12-02 | 2003-10-21 | Ct Ingenieria Genetica Biotech | Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal |
US20030072764A1 (en) * | 2001-04-05 | 2003-04-17 | O'hagan Derek | Mucosal boosting following parenteral priming |
US20090306341A1 (en) | 2005-07-29 | 2009-12-10 | Joachim Emmert | LC/MS Blends Containing Ionizing Additives |
DK2014305T3 (en) | 2006-04-21 | 2017-10-16 | Toko Yakuhin Kogyo Kk | SPRAYABLE GEL-SHAPED SKIN / MOSPHONE ADHESIVE AND ADMINISTRATIVE SYSTEM FOR USING THE PREPARATION |
US9603919B2 (en) | 2009-03-31 | 2017-03-28 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
EP2832452B1 (en) | 2012-03-30 | 2017-02-01 | Yoshino Kogyosho Co., Ltd. | Metered-dose syringe type spray device |
CN106573045B (zh) * | 2014-06-25 | 2020-10-27 | 东兴药品工业株式会社 | 流感疫苗经鼻接种系统 |
JP6322844B2 (ja) * | 2014-06-25 | 2018-05-16 | 東興薬品工業株式会社 | 医療用シリンジに用いられる点鼻用噴霧ノズル |
JP6558392B2 (ja) * | 2017-04-04 | 2019-08-14 | ニプロ株式会社 | シリンジ型噴出装置 |
-
2019
- 2019-06-04 IL IL278415A patent/IL278415B2/en unknown
- 2019-06-04 TW TW108119325A patent/TW202002950A/zh unknown
- 2019-06-04 CU CU2020000097A patent/CU24686B1/es unknown
- 2019-06-04 CA CA3099430A patent/CA3099430A1/en active Pending
- 2019-06-04 CN CN201980035576.2A patent/CN112368018A/zh active Pending
- 2019-06-04 SG SG11202011004RA patent/SG11202011004RA/en unknown
- 2019-06-04 BR BR112020022784-6A patent/BR112020022784A2/pt unknown
- 2019-06-04 JP JP2020523114A patent/JPWO2019235466A1/ja active Pending
- 2019-06-04 MX MX2020013240A patent/MX2020013240A/es unknown
- 2019-06-04 KR KR1020207038093A patent/KR20210022009A/ko unknown
- 2019-06-04 AU AU2019283122A patent/AU2019283122A1/en active Pending
- 2019-06-04 EP EP19816086.3A patent/EP3804752A4/en active Pending
- 2019-06-04 US US15/734,148 patent/US20210187101A1/en active Pending
- 2019-06-04 WO PCT/JP2019/022136 patent/WO2019235466A1/ja active Application Filing
-
2020
- 2020-12-03 PH PH12020552075A patent/PH12020552075A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL278415A (ko) | 2020-12-31 |
CU20200097A7 (es) | 2021-07-02 |
IL278415B1 (en) | 2023-06-01 |
MX2020013240A (es) | 2021-05-12 |
BR112020022784A2 (pt) | 2021-02-02 |
CA3099430A1 (en) | 2019-12-12 |
TW202002950A (zh) | 2020-01-16 |
EP3804752A1 (en) | 2021-04-14 |
AU2019283122A1 (en) | 2020-11-26 |
IL278415B2 (en) | 2023-10-01 |
WO2019235466A1 (ja) | 2019-12-12 |
PH12020552075A1 (en) | 2021-05-31 |
JPWO2019235466A1 (ja) | 2021-06-24 |
KR20210022009A (ko) | 2021-03-02 |
US20210187101A1 (en) | 2021-06-24 |
CU24686B1 (es) | 2023-11-07 |
EP3804752A4 (en) | 2022-03-09 |
CN112368018A (zh) | 2021-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256169A1 (zh) | 傳染病疫苗 | |
IL258833A (en) | Make simple shingles virus | |
HK1255847A1 (zh) | 針對乙型肝炎病毒的疫苗 | |
MA52645A (fr) | Vaccins contre le virus respiratoire | |
ZA201904717B (en) | Therapeutic hpv18 vaccines | |
MA47677A (fr) | Vaccins peptidiques | |
ZA201807048B (en) | Medical delivery system | |
GB201705765D0 (en) | HBV vaccine | |
EP3148566C0 (en) | SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION | |
EP3515929A4 (en) | THERAPEUTIC VACCINE AGAINST HEPATITIS B | |
MA53543A (fr) | Vaccins peptidiques | |
GB201910794D0 (en) | Vaccine | |
SG11201808268UA (en) | Recombinant hansenula-based high dosage hepatitis b vaccine | |
GB201616904D0 (en) | Vaccine | |
EP3866847A4 (en) | ANTIVIRAL VACCINE | |
SG11202011004RA (en) | Hepatitis b vaccine transnasal administration system | |
GB201811382D0 (en) | Vaccine | |
GB201818308D0 (en) | HIV Vaccine | |
GB201818307D0 (en) | HIV Vaccine | |
GB201911636D0 (en) | Vaccine | |
GB201807303D0 (en) | Glyconjugate vaccines | |
AU2018903913A0 (en) | Virus Vaccine | |
GB201702193D0 (en) | Hepatitis E virus vaccine | |
GB201717288D0 (en) | Hiv vaccine | |
GB201712904D0 (en) | Vaccine |